- Home
- » Tags
- » Vanucizumab
Top View
- NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
- List of Abbreviations
- Bi-Specific and Tri-Specific Antibodies- the Next Big Thing in Solid Tumor Therapeutics Karie Runcie1, Daniel R
- WO 2017/176762 Al 12 October 2017 (12.10.2017) P O P C T
- (INN) for Biological and Biotechnological Substances
- Therapeutic Targeting of the Angiopoietin–TIE Pathway
- Bispecific Antibodies and Antibody–Drug Conjugates for Cancer
- Antibody Drug Nomenclature: -Umab -Zumab -Ximab
- Research and Clinical Landscape of Bispecific Antibodies for The
- 6.6.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- International Nonproprietary Names for Pharmaceutical Substances (INN)
- Angiopoietin-2/Anti-VEGF-A Antibody
- One for Treatment of Solid Cancers
- A Year of Challenges, Opportunities and Hope. Vall D'hebron Institute of Oncology (VHIO) CELLEX CENTER C/Natzaret, 115 – 117 08035 Barcelona, Spain Tel
- Monoclonal Antibodies and Chimeric Antigen Receptor
- WO 2017/053807 A2 30 March 2017 (30.03.2017) P O P C T
- Poly Specific Antibodies
- Colorectal Cancer: from Genetic Landscape to Targeted Therapy
- Global Drug Forecast and Market Analysis to 2023
- Phase Ib Study of Anti-CSF-1R Antibody Emactuzumab In
- Search for Therapeutic Targets at the Contact Points of the Tumor Cell with Its Extracellular Matrix in Neuroblastic Tumors
- Breast Cancer Cancer Drug Pipeline Information for Patient Advocacy
- (2006.01) C07d 413/14
- Oncology Drugs in the Pipeline
- Anàlisi De La Despesa Farmacèutica En El Tractament De Tumors Sòlids a L'hospital Universitari Vall D'hebron I La Seva Co
- (INN) for Biological and Biotechnological Substances
- Antonio Cubillo Gracian, MD., Ph.D. (Aug 1St, 1970) BIOSKETCH: 1. EDUCATION
- Université Clermont-Auvergne
- A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
- First-In-Human Phase I Study of Single
- Comprehensive Review of Targeted Therapy for Colorectal Cancer
- Methodology Results Background
- INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
- Andrés Cervantes Ruipérez Generated From: Editor CVN De FECYT Date of Document: 28/02/2020 V 1.4.0 8C4676074e67ccbfb063ec8ab91881dc
- New Soluble Angiopoietin Analog of C4BP-ANG1 Prevents Pathological Vascular Leakage